Hangzhou Minsheng Healthcare Co Ltd (301507.SZ) stock: key figures, P/E, revenue and dividend

Health Care · China · ISIN CNE1000068Q3

Price
11.57 CNY
Market cap
4.13 bn CNY
P/E (2025)
34.73
P/S (2025)
5.28
Dividend yield
1.30 %
Net margin
15.20 %
Return on equity (ROE)
6.91 %
Return on assets (ROA)
5.89 %

Hangzhou Minsheng Healthcare Co Ltd financials

Fiscal year20242025
Revenue641.25 m CNY781.63 m CNY
Gross profit357.63 m CNY399.41 m CNY
Operating income84.37 m CNY91.91 m CNY
EBIT106.32 m CNY137.54 m CNY
Net income91.83 m CNY118.79 m CNY
Diluted EPS – continuing operations0.26 CNY0.33 CNY

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Hangzhou Minsheng Healthcare Co Ltd

Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and healthy foods in China and internationally. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also provides multivitamin, vitamin, and zinc selenium with mineral tablets; and glucosamine chondroitin colostrum protein chewable, vitamin soft capsules and chewable, iron folic acid, melatonin, coenzyme soft capsules, and calcium magnesium vitamin D tablets. The company offers its products under the 21 SUPER-VITA brand name. Hangzhou Minsheng Healthcare Co., Ltd. was founded in 1926 and is based in Hangzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.